Saad Munib AhmedKhanMD

PubMed

• 7 citations
  Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase ...
  Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, Christine H Chung, Nadeem Riaz, G Brandon Gunn, Robert L Foote, Sue S Yom, Stuart J Wong, ...> ;The Lancet. Oncology. 2023 Feb 1
• 98 citations
  Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2,...
  Vivek Subbiah, Jürgen Wolf, Bhavana Konda, Hyunseok Kang, Alexander Spira, Jared Weiss, Masayuki Takeda, Yuichiro Ohe, Saad Khan, Kadoaki Ohashi, Victoria Soldatenkova...> ;The Lancet. Oncology. 2022 Oct 1
• 4 citations
  A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma ...
  Luke S McLean, Tessa A Morris, Ann Gramza, Stephen Liu, Saad A Khan, A Dimitrios Colevas, Tillman Pearce, Danny Rischin> ;Investigational New Drugs. 2022 Aug 1
• 13 citations
  Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.
  Ramaswamy Govindan, Mike Lind, Amelia Insa, Saad A Khan, Dmitry Uskov, Ali Tafreshi, Salih Guclu, Jair Bar, Terufumi Kato, Ki Hyeong Lee, Kazuhiko Nakagawa, Olfred Han...> ;Clinical Lung Cancer. 2022 May 1
• 2 citations
  Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
  Abdelrahman Sherif Abdalla, Natasha D Sheybani, Saad A Khan> ;PET Clinics. 2022 Apr 1
• 2 citations
  Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: A national...
  Andrew T. Day, Alex M. Yang, Priscilla J. Tanamal, James-Michael Blackwell, Baran D. Sumer, Justin A. Bishop, Randall S. Hughes, Saad A. Khan, David J. Sher> ;Head & Neck. 2021 Jul 31
• 12 citations
  Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors
  , , , , , , , , , , , , , , , > ;Journal for Immunotherapy of Cancer. 2021 Jun 1
• 6 citations
  Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).
  Saad A. Khan, Z. Sun, Suzanne E. Dahlberg, Jyoti Malhotra, Roger Keresztes, Chukwuemeka Ikpeazu, Patrick Ma, Suresh S. Ramalingam, Rathi N. Pillai> ;JTO Clinical and Research Reports. 2021 May 1
• 26 citations
  Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer.
  David J. Sher, Nhat-Long Lam Pham, Jennifer L Shah, Neilayan Sen, Kimberly A. Williams, Rathan M. Subramaniam, William Moore, Regina Chorley, Chul Ahn, Saad M. Khan> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Mar 15
• 5 citations
  Genomic Analysis of Salivary Gland Cancer and Treatment of Salivary Gland Cancers.
  Doreen N. Palsgrove, Sameer Allahabadi, Saad A. Khan> ;Surgical Pathology Clinics. 2021 Jan 5
• 9 citations
  Survivin expression and impact on head and neck cancer outcomes.
  Saad A. Khan, Michael Burke, Fang Zhu, Dong-Hua Yang, Cara Dubyk, Ranee Mehra, Miriam J. Lango, John A. Ridge, David J. Sher, Barbara Burtness> ;Oral Oncology. 2021 Jan 1
• 1 citations
  Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysis.
  David J. Sher, Jingsheng Yan, Andrew T. Day, Saad A. Khan, Hong Zhu> ;Oral Oncology. 2021 Jan 1
• 16 citations
  Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
  Johanna C. Bendell, Sunil Sharma, Manish R. Patel, Kevin S Windsor, Zev A. Wainberg, Michael S. Gordon, Jordan Berlin, Carrie Baker Brachmann, Marianna Zavodovskaya, J...> ;The Oncologist. 2020 Nov 1
• 8 citations
  Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A “Two‐Hit” Autoimmune Toxicity or Clinical Predisposition?
  Mitchell S. von Itzstein, Shaheen Khan, Vinita Popat, Rong Lu, Saad A. Khan, Farjana J. Fattah, Jason Y. Park, Bonnie L. Bermas, David R. Karp, Murtaza Ahmed, Jessica ...> ;The Oncologist. 2020 Aug 1
• 83 citations
  Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.
  Andrew T. Day, David J. Sher, Rebecca Lee, John M. Truelson, Larry L. Myers, Baran D. Sumer, Lenka Stankova, Brittny N. Tillman, Randall S. Hughes, Saad A. Khan, Eli G...> ;Oral Oncology. 2020 Jun 1
• 15 citations
  Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon.
  Shaheen Khan, Mitchell S. von Itzstein, Rong Lu, Bonnie L. Bermas, David R. Karp, Saad A. Khan, Farjana J. Fattah, Jason Y. Park, Jessica Saltarski, Yvonne Gloria-McCu...> ;The Oncologist. 2020 May 1
• 17 citations
  Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.
  Ruth Sacks, Jennie Y Law, Hong Zhu, Muhammad Shaalan Beg, David E. Gerber, Baran D. Sumer, Larry L. Myers, John M. Truelson, Lucien A. Nedzi, David J. Sher, Randall S....> ;Oncology. 2020 Jan 1
• 2 citations
  Head and neck neuroendocrine tumors at a single institution over 15 years.
  Maria Bacalao, Muhammad Shaalan Beg, Dominick Cavuoti, Hong Zhu, Baran D. Sumer, Larry L. Myers, John M. Truelson, Lucien A. Nedzi, David J. Sher, Randall S. Hughes, S...> ;Clinical Case Reports. 2019 Nov 17
• 1 citations
  Confluent tracheal recurrences of head and neck squamous cell carcinoma.
  Benjamin Aaron Bleiberg, Muhanned Abu-Hijleh, William Moore, Saad A. Khan> ;Clinical Case Reports. 2019 Aug 16
• 18 citations
  Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling
  Saad A. Khan, Bo Ci, Yang Xie, David E. Gerber, Muhammad Shaalan Beg, Steven I. Sherman, Maria E. Cabanillas, Naifa L. Busaidy, Barbara Burtness, Andreas M. Heilmann, ...> ;Head & Neck. 2019 Jun 1
• 15 citations
  Risk of Unplanned Hospital Encounters in Patients Treated With Radiotherapy for Head and Neck Squamous Cell Carcinoma.
  Zachary R. Moore, Nhat-Long Lam Pham, Jennifer L Shah, Lucien A. Nedzi, Baran D. Sumer, Andrew T. Day, Saad A. Khan, David J. Sher> ;Journal of Pain and Symptom Management. 2019 Apr 1
• 34 citations
  Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.
  Masato Kobayashi, Jin Sung Chung, Muhammad Shaalan Beg, Yull Edwin Arriaga, Udit Verma, Kevin D. Courtney, John C. Mansour, Barbara Haley, Saad A. Khan, Yutaka Horiuch...> ;Clinical Cancer Research. 2019 Jan 15
• 112 citations
  Immune dysregulation in cancer patients developing immune-related adverse events.
  Shaheen Khan, Saad A. Khan, Xin Luo, Farjana J. Fattah, Jessica Saltarski, Yvonne Gloria-McCutchen, Rong Lu, Yang Xie, Quan Li, Edward K. Wakeland, David E. Gerber> ;British Journal of Cancer. 2019 Jan 8
• 13 citations
  Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.
  David J. Sher, Jingsheng Yan, Andrew T. Day, Baran D. Sumer, Nhat-Long Lam Pham, Saad A. Khan, Hong Zhu> ;Oral Oncology. 2019 Jan 1
• 12 citations
  Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.
  Vasu Tumati, Lawrence Hoang, Baran D. Sumer, John M. Truelson, Larry L. Myers, Saad A. Khan, Randall S. Hughes, Lucien A. Nedzi, David J. Sher> ;Head & Neck. 2018 Dec 13
• Join now to see all